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Drugs used in the chemotherapy of cancer have also been used as ]mmuno- 
suppressive agents for the control of jrnrnune mechanisms involving antibody 
production, and cell-mediated forms of immunity such as delayed-type hyper- 
sensitivity and transplantation immunity (1-5);  there are, however, few pub- 
lished reports of their effect on the immune response to microorganisms despite 
infection being  a  serious  complication of  their use in  clinical practice.  The 
present report deals with the influence of some immunosuppressive drugs on 
the ~rnmune response to a facultative intracellular parasite. 
Tuberculosis, brucellosis, listeriosis,  and salmonellosis are examples of infec- 
tions which give rise to a cell-mediated form of immunity  which evolves through 
similar mechanlqms (6); it is therefore logical to assume that observations on 
one host-parasite system will have relevance to the others. Listeriosis in the 
mouse has been chosen as a model for the present study because it offers several 
advantages. Firstly, the immune response sets in early and runs a short course, 
so that an immunosuppressive effect is quickly revealed; secondly, a  L/ster/a 
infection,  as  assessed  by  bacterial  enumeration,  provides  an  accurate  and 
quantitative assessment of immunity and the magnitude of the immunosup- 
pressive  effect obtained with drugs.  Mice  infected with a  sublethal  dose of 
Listeria monocytogenes develop an immune response which interrupts the growth 
of the organism in vivo. The experiments to be described are based upon the 
premi.~e that effective suppression of the immune response by drugs would result 
in continued multiplication of L/ster/a, particularly in the spleen and liver. 
Four drugs, representing four different categories of cytotoxic agents, were 
chosen for  study:  (a)  cyclophosphamide, a  polyfunctional alkylating agent; 
(b) vinblastine, an antimitotic agent; (c) methotrexate, a folic acid antagonist; 
and (d) azathioprine, a purine analogue. The present report deals with the effect 
of these four drugs on the immune response to Listeria infection in mice. 
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Materials and Methods 
M/ce.--Female specific  pathogen-free  (SPF)  mice derived from  COBS progenitors were 
used. The mice were about 5-7 wk old and usually weighed between 18 and 22 g at the time of 
infection. 
Infecting Stradn.--Listeria monocytogenes, strain EGD, was used. This strain has been main- 
tained in this laboratory by alternate passage in the mouse spleen and trypticase soy broth 
(TSB) medium. It has remained in the smooth phase and has an intravenous ~v60 of approxi- 
mately 5 X  i03 viable units. Growth was unaffected by 100 t~g/ml of cyclophosphamide, vin- 
blastine, methotrex&te, or azathioprine when the strain was exposed to these drugs in TSB 
medium in vitro. 
Infection.--The bacterial content in a  logarithmic phase culture of L. m0nocytogenes was 
determined by direct count  (Petroff-Hausser).  It was appropriately diluted in Hanks' Bal- 
anced Salt Solution to contain the desired number of bacteria in 0.2 ml, the volume used to 
infect animals by intraveous injection. A viable count of the inocuium suspension was invari- 
ably made by plating appropriate dilutions of the suspension on trypticase soy agar (TSA) 
medium. 
Bacterial Enumeration in Liver and Spteen.--Autopsies  were conducted on five mice from 
each group at each time-point. Five mice were killed 10 rain after injection to establish the 
initial bacterial content in spleens and livers; thereafter bacterial counts were made at intervals 
on five mice from each group at each time-point. 
The  mice were  killed by cervical dislocation. Organs were  removed  aseptically to  ho- 
mogenizer tubes containing 8 ml (for liver) or 9 ml (for spleen) of TSB medium, giving final 
volumes of approximately 10 ml. They were dispersed for 1 rain with a Teflon homogenizer. 
Appropriate serial dilutions of each homogenate were then plated on TSA medium. The viable 
bacterial content of the viscera was estimated from colony counts after overnight incubation 
at 37°C.  The geometric means of the viable counts of Listeria in the livers and spleens were 
calculated separately for each group. All the results have been presented in this report as mean 
viable counts expressed on a logarithmic scale. 
Drug Treatment.--MTX~  (Lederle Laboratories, Division of American Cyanamid Co., Pearl 
River N. Y.), CY  1 (Cytoxan, Mead Johnson & Co., Evansville, Ind., and AZT  1 (Imuran, gen- 
erously supplied by Burroughs Wellcome & Co., Tuckahoe, N.Y.) were administered subcutane- 
ously as aqueous solutionsin 0.25 ml  containing doses equivalent to 50, 200, and 200 mg/kg body 
weight, respectively. VLB~  (vincaleucoblastine sulfate, Velban, Eli Lilly and  Co., Indiana- 
polls, Ind.) was administered intravenously in a dose of 4 mg/kg, contained in 0.1 mi. Unless 
otherwise specified,  all drugs were given as single dose treatments,  administered on the day 
specified.  The dosages selected represent the maximum tolerated dose for each drug, based on 
observations of Berenbaum and Brown (7) for cyclophosphamide and vinblastine and our own 
unpublished observations on all four drugs. 
RESULTS 
Listeria Growth Pattern in Normal Mice.-- 
A preliminary study was undertaken to determine the most suitable infecting dose of Listeria 
monocytogenes. Four groups  of mice were infected with varying doses of L. monocytogenes. 
Viable counts were performed at frequent intervals thereafter, as recorded in Fig. 1. 
The course of infection in the liver was similar in all four groups  during the 
first 24 hr. Beyond that time, the shape of the growth curve was dependent upon 
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the infecting dose. All groups showed an initial fall, ranging from 30-81%  at 
3  hr; thereafter, there was a  steady and parallel rise during the next 21  hr. 
Between 24 and 48 ha', bacterial growth continued unchecked only in the ani- 
mals infected with the largest dose of organisms; all others showed an inflec- 
tion which was interpreted as evidence of an immune response on the part of 
the host tending to limit further multiplication of the organisms. 
The spleen counts showed no evidence of an initial fall; growth continued 
log-linearly in the spleen for only 12 hr. Thereafter, there was a change in the 
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Fro. 1.  Growth curves of L. monocytogenes in livers and spleens of mice infected at varying 
dose levels. Each plot represents the mean from five mice. 
slope, most marked at lower dose levels. Although the growth curve indicates 
some inhibition with the largest infecting dose, the effect is spurious since it 
results from the inability of a necrotic spleen to support a bacterial population 
much larger than l0  s Listeria. 
It is apparent that the effect of developing resistance is most obvious in both 
liver and spleen with a  low infecting dose of organisms. For this reason the 
effect of immunosuppressive drugs was studied in animals infected with less 
than los bacteria. 
The Course of Infection in Mice Treated with a Single Dose of Drug on the 
Day of Infection.-- 
Three groups of mice infected with 2  X  10  a Lister~ were treated with single injections of 
cyclophosphamide, vinblastine, and methotrexate; the course of infection in the three groups 
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was plotted daily, using five mice from each group at each time-point. The growth curves were 
compared with those in control mice which received no treatment.  The results are recorded in 
Fig. 2. 
The liver counts indicated that untreated mice exhibited an immune response 
resulting  in  effective  control  of  bacterial  multiplication  beyond  24  hr.  In 
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FIo. 2.  Growth curves of L.  monocytogcne.s in the livers  and  spleens of untreated  mice 
(control)  and  mice given a single dose of cyclophosphamide  (CY),  vinblastine  (VLB), or 
methotrex&te (MTX) on the day of infection. All remaining mice in groups VLB and CY died 
between days 3 and 4. 
contrast,  the  immune  response  was  effectively suppressed  in  the  three  drug- 
treated  groups,  as  evidenced  by  continued  bacterial  growth.  In  comparison 
with the controls, bacterial counts at 48 hr were significantly higher for cyclo- 
phosphamide  (P  <  0.05),  vinblastine  (P  <  0.01),  and methotrexate  (P  < 
0.05).  The bacterial  content  continued  to increase  between  48  and  72  hr  in 
cyclophosphamide- and vinblastine-treated  mice,  resulting  in the death  of all 
remaining mice between 3 and 4 days. 
The  effects  of methotrexate  were  markedly  different  from  those  of  cyclo- S.  P.  TRIPATHY  AND  G.  B.  MACKANESS  5 
phosphamide and vinblastine. Its immunosuppressive effect persisted for only 
48 hr, as is evidenced by the shape of the curve beyond that time. This suggests 
that  the  ;mmunosuppressive  effect of methotrexate,  in  contrast  to  that  of 
cyclophosphamide or vinblastine, is reversible. 
The  course  of  infection in  the  spleen  presented  broadly similar  features 
except that the magnitude of the differences between the bacterial populations 
in the drug-treated and the control groups was smaller. 
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FIG. 3.  Growth curves of L. monocytog~f~s in control mice and mice treated with a single 
injection of azathioprine (AZT) at the time of infection. 
In  a  similar  experiment,  the  influence of  azathioprine  was  studied.  The 
results, presented in Fig. 3, showed that azathioprine completely suppressed the 
immune response;  the differences between the  control and the  drug-treated 
groups at 72 and 96 hr attained significance (P <0.05 and <0.01, respectively). 
Effect of Repeated Administration of Metkotrexate on the Course of Infection.-- 
The transient nature of the immunosuppression achieved with a single injection 
of methotrexate on the day of infection prompted a study to determine whether 
an immunosuppressive effect could be  sustained by the administration of a 
second injection of MTX at 24 hr. The results, presented in Fig. 4, showed that 
complete suppression of immunity was achieved only in animals which received 
a second injection of methotrexate. 6 
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Fzo. 4.  Growth curves of L. monoc)Cogenes showing the effects of a  single dose of metho- 
trexate given at the time of infection (MTX-1); and of two doses given at infection and 24 hr 
later (MTX-2). 
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TimemReSponse Relationship.--It has been shown that a single dose of drug 
admlni.~tered at the time of infection effectively suppressed the immune response 
to a Listeria infection. It was of interest to study next the immunosuppressive 
effects produced with a single dose administered at varying times before and 
after the initiation of infection. 
The results of treatment with cyclophosphamide administered before or after 
the initiation of infection are contained in Figs. 5 and 6. They show that the 
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FIo. 6.  Growth curves of L. mortoaytogenes in control mice and in mice given a single dose of 
cyclophosphamide at 24 (T+~4) and 48 (T+o) hr after infection. 
drug produced conspicuous impairment of the immune response when given as 
early as 48 hr before infection (Fig. 5). It was also capable of interfering with 
an ongoing response, as indicated by the curves obtained in animals treated 24 
or 48 hr after infection (Fig. 6). 
The data presented in Figs 5 and 6 can be used to express drug effects in 
terms of an immunosuppressive index; i.e., the difference between the log viable 
counts in  drug-treated and control groups  at  any time.  Since drug-treated 
animals do not always survive beyond 3 days of drug-host-parasite  interaction, 
the bacterial counts at 72 hr were chosen for expressing the immunosuppressive 
index in the following studies with cyclophosphamide, vinblastine,  and metho- 8  EFFECT  OF  CYTOTOXIC  AGENTS  ON  ngMLrNE  P,  ESPONSE 
trexate. The experimental plan was similar to that used in the previous experi- 
ment. 
Using the immunosuppressive index as defined above, the degree of immuno- 
suppression obtained with a single injection of cyclophosphamide, vinblastine, 
and methotrexate administered at periods ranging from II days before to 7 days 
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FIo. 7.  Plots showing the differences in the immunosuppressive indices obtained in the 
liver when single doses of cyclophosphamide (CY), vinblastine (VLB), or methotrexate (MTX) 
were administered at varying times before  (--11 to  --1  days) or during (0 to  -J-7 days)  a 
Listeria infection. 
after the initiation of infection was measured. The results are presented in Figs. 
7 and 8. Considering first the effects observed in the liver, it is apparent that 
cyclophosphamide was immunosuppressive over a broad interval of time, from 
--2 to +4 days, its influence being virtually maximal during this period. Vin- 
blastine, on the other hand, produced its greatest effect when given at the time 
of infection. It had only a slight influence when given prior to infection but was 
very active when given during the first 48 hr after infection. In the case of 
methotrexate, maximum activity was achieved in animals treated 48 hr after. 
An interesting feature of the curves shown in Fig. 7 was the negative immuno- S. P. TRIPATHY  AND  G. B. MACKANESS 
suppressive  index  observed  in  animals  treated  with  cyclophosphamide and 
vinblastine 7-11  days before infection, and a similar effect with methotrexate 
given 4 days before infection. This immunity-enhancing influence of immuno- 
suppressive  drugs when given prior  to  an immunological stimulus has been 
observed in other systems and will be discussed in greater detail later. 
The immunosuppressive indices in the spleen (Fig. 8)  were broadly similar 
but showed a tendency for the curves to shift to the right. 
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FZO. 8. Plots showing the differences  in the immunosuppressive  indices obtained in the 
spleen when single doses of cyclophosphamide (CY), vinblastine (VLB), or methotrexate 
(MTX) were admlnlgtered  at varying  times  before (  -- 11 to -- 1 days) or during  (0 to +7 days) 
a  Listeria infection. 
DISCUSSION 
Many  cytotoxic  agents  owe  their  immunosuppressive  activity  to  their 
capacity to attack rapidly proliferating cells. Their action on humoral antibody 
production  (1-4)  or  ceU-mediated forms of  immunity such  as  delayed-type 
hypersensitivity (5) and transplantation immunity (8, 9), have provided valu- 
able information concerning the cellular events associated with these types of 
immune response. There have, however, been few studies concerned with their 
effect upon acquired resistance  to infectious diseases,  even though infection 
represents the major hazard associated with the use of such agents. 10  EFFECT  OF  CYTOTOXIC AGENTS ON  IMMUNE RESPONSE 
Our investigations  have shown that administration of a single dose of any 
one of four broadly representative cytotoxic agents has profound effects on the 
course of Listeria infection in mice. It is of interest to consider what known ef- 
fects of these cytotoxic agents could be held responsible for the results obtained. 
Since infection with intracellular  parasites results in a cell-mediated form of im- 
munity (10, 11), it is appropriate to discuss them in relation to reported findings 
of their action on delayed-type hypersensitivity and transplantation immunity. 
The ultimate expression of resistance against intracellular bacterial parasites 
rests with the macrophage  and not with the lymphoid cells which mediate the 
mechanism of immunity (10, 11). It is therefore possible that some of the effects 
observed might be due to interference with the activities of macrophages. That 
this is not a major factor is evidenced by findings, to be reported later,  ~ which 
show that animals immunized with a heterologous organism (BCG) retain their 
resistance to challenge with L. monocytogenes after treatment with cyclophos- 
phamide,  vinblastine,  or  methotrexate.  Since this  nonspecific  resistance  is 
known to be due to activated macrophages,  it is reasonable  to conclude that 
none of these drugs has any major influence on the functional activity of macro- 
phages. Moreover, 6-mercaptopurine,  a purine analogue similar to azathioprine, 
does not influence the rate of clearance of heterologous erythrocytes from blood 
(12), nor does nitrogen mustard (believed by some to be the active form of 
cyclophosphamide)  affect the particle cleating  function of the reticuloendo- 
thelial system (13). These observations  again indicate a lack of direct toxicity 
for the macrophage. It would appear therefore that most of the effects observed 
in the present study can be attributed to the influence of the drugs on the lym- 
phoid cells which become engaged in the immune response leading to acquired 
resistance.  More persuasive  evidence on this point is presented in an accom- 
panying paper (28). 
There are at least three ways of interfering  with an immune response:  (a) 
depletion of immunocompetent cells by direct cytolysis; (b) impairment of cell 
metabolism; and (c)  selective destruction, with mitotic poisons, of those cells 
which divide in the course of the immune response. The results obtained with 
the four drugs  will be discussed in relation to these  three possible modes  of 
action. 
The exact mechanism of induction of cellular immunity in listeriosis is as yet 
ill-defined. Present evidence indicates that it may be similar to the induction of 
delayed-type hypersensitivity (10, 11). Turk (5)  has proposed  that the steps 
leading to this type of hypersensitivity  involve the sequence: small lymphocyte 
--+ immunoblast --* immunologically committed small lymphocytes. That the 
immune mechanism  in listeriosis is mediated through the lymphoid series of 
s Mackaness, G. B., and S. P. Tripathy. 1969. The effect of cytotoxic agents on established 
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cells and not by serum antibody, is indicated by recent studies from this labora- 
tory which show that lymphoid cells from L/s~r/a-immune mice are capable of 
conferring  absolute immunity to Listeria challenge when transferred to normal 
recipients (10); and that specific antilymphocyte globulin  abolishes the protec- 
tion conferred in this way (11). The occurrence of pyroninophilic cells (similar 
to the pyroninophilic "immunoblasts" of Turk)  in the spleens  of mice during 
the early stages of infection  a indicates that the evolution of the immune lym- 
phoid cells in listeriosis  could well involve the sequential stages: precursor cell 
---> immunoblast ---> immunologically committed small lymphocytes. It is clear 
that immunosuppressive drugs could act on any of these three cell populations. 
Cyclophosphamlde,  a  member of the mustard  series,  belongs  to a  class  of 
drugs designated as polyfunctional alkylating agents which have been shown to 
exert their toxic action on cells by forming crosslinks between double-stranded 
DNA, interfering with transcription and replication (14).  Studies with ascites 
tumor ceils have shown that the drug acts on the premitotic resting phase (G~), 
as well as on the DNA-synthetic phase (S) of the ceil cycle (15); it is toxic to 
precursor ceils of both the erythroid and  the lymphoid series  (16).  Nitrogen 
mustard (and presumably cyclophosphamide) is directly lethal for lymphocytes 
(17).  It  would seem therefore  that  cyclophosphamide has  the  potential  to 
damage lymphoid cells at all stages of the immune response.  Turk's investiga- 
tions on delayed-type hypersensitivity suggest that  it acts in  three ways: it 
prevents the differentiation of small lymphocytes to immunoblasts; has a direct 
toxic action on immunoblasts;  and is antimitotic.  Our observations are con- 
sistent with  this view since cyclophosphamide was found to have a profound 
effect on the host's resistance when given at any time from 2 days before to 4 
days after infection,  suggesting  that  it  can  affect  the  precursor  cell,  the 
intermediate  cell,  and possibly the immunologically  committed small lympho- 
cyte. 
Vinblastine sulphate is known to act on dividing ceils (18); it prevents the 
formation of the mitotic spindle, causing arrest in metaphase. Its effects are be- 
lieved to be irreversible so that arrested cells ultimately die. The immunosup- 
pressive effects obtained with vinblastine in the present study are therefore a 
reflection  of the mitotic activity occurring during a  normal immune response 
and thus throw some light on the cellular events which occur during the initial 
stages of the host's immune response to L. monocytogenes. 
The slope of the normal growth curve from 12 to 24 hr (Fig.  1) indicates that 
the host's immune response is already manifest in the spleen at 24 hr.  Radio- 
autographic studies on spleens  of L/ster/a-infected mice show marked mitotic 
activity at this time.  8 A relationship between this mitotic response and the de- 
s North, R. J. 1969. Cdlular kinetics associated with the development of acquired cellular 
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velopment of immunity is indicated by the immunosuppressive effect obtained 
with a single dose of vinblastine administered at the lime of infection.  In fact, 
vinblastine was most effective when given at this time, suggesting that the 
presence of vinblastine for 15-18 hr (the duration of effective serum levels of 
vinblastine with the dosage employed) results in the deletion of a/l cells which 
have become mitotically engaged as a result of the immune response. This would 
interfere drastically with the natural transition from the precursor cell to im- 
munologically committed small lymphocyte, and hold the host's acquired de- 
fenses in abeyance. 
Azathioprine and methotrexate are antimetabolites which specifically inter- 
fere with the processes leading to the synthesis of DNA. Azathioprine prevents 
the conversion of inosinic acid to adenylic acid, an essential step in the synthesis 
of nucleic acids; it may, in addition, act through binding of sulfhydryl groups 
(1). Since a single dose of azathioprine, given at the time of infection, effectively 
suppresses the immune response (Fig. 3), its effects would seem to be irrever- 
sible in contrast to those of methotrexate (Fig. 2), 
The most important biochemical lesion caused by methotrexate is a result of 
its profound influence on folic reductase. This enzyme reduces folic acid to di- 
hydrofolic acid and tetrahydrofolic acid, thereby interfering with the formation 
of thymidine (19). The drug is believed to be bound irreversibly to the enzyme 
so that methotrexate treatment results in thymidine deficiency and impairment 
of DNA synthesis. 
The  present  studies showed  two features which  distinguish the  effect of 
methotrexate from those produced by other drugs. The time-response relation- 
ship showed that the immunosuppressive activity of methotrexate was highest 
when the drug was administered at 48 hr after infection, indicating that the drug 
probably acts most effectively  at a later stage of the immune response. Turk (5) 
suggested from morphologic studies that methotrexate acts principally on the 
transformation of immunoblasts to immunologically committed small lympho- 
cytes. North's studies  3 indicate that the maximum mitotic activity (predomini- 
nantly involving immunoblasts) is found in the spleens at 48 hr after Lisleria 
infection. If Turk's conclusions are applicable to the present model, it would be 
at this time that methotrexate would exert its greatest effect in suppressing the 
immune response to Listeria, a premise which is borne out by the findings; it is 
not dear, however, whether the immunosuppressive effect is due to interference 
with further cell division, cell differentiation, or both. 
Another feature of interest was the reversible nature of immunosuppression 
with methotrexate. Since many tissues have reserves of tetrahydrofolic acid, the 
end-product of folic reductase activity, it is possible that after a single dose of 
methotrexate the reserves of tetrahydrofolate may be adequate to tide over the 
toxic effect of methotrexate toxicity. Under these conditions it is possible that 
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ensue.  It is also possible that the reversible  nature of the immunosuppressive 
activity may be due to the persistence of some lymphoid cells with greatly ele- 
vated levels of folic reductase, a situation which has been encountered in some 
tumor cells which survive chemotherapy with methotrexate (20-22). The total 
immunosuppression achieved with two doses of methotrexate, while in favor of 
the former, suggests that  the latter explanation  is unlikely.  The results thus 
indicate that cells can escape from the lethal action of this drug unless its levels 
are sustained. 
The transient nature of methotrexate activity is also seen with other immune 
systems. Friedman  and Buckler (23)  observed that  while  methotrexate sup- 
pressed the induction of delayed-type hypersensitivity to tuberculin in guinea 
pigs,  lymph  node  cells  from  these animals  were capable of transferring  sen- 
sitivity to normal recipients  2 wk later. The authors interpreted this finding to 
mean that methotrexate prevents the multiplication of sensitized  cells but does 
not interfere with the induction of the immune response.  The results of the 
present  study give strong support  to  this view.  Fig.  2 shows that  bacterial 
populations in  animals  treated  with methotrexate had  reached levels higher 
than 10 million without any overt evidence of an immune response on the part 
of the host. Since this number of organisms  is invariably lethal to mice (LDs0 
5  )<  l(P),  yet the methotrexate-treated  animals  effectively controlled  them 
from the 2nd day onwards, it seems that the immune response had proceeded 
in the presence of methotrexate to the extent that cells had been primed during 
the early stages; on being released from the effect of methotrexate, the primed 
cells must have undergone a sudden burst of activity, resulting in an effective 
immune response. 
In  the  present  study,  pretreatment  with three  immunosuppressive  drugs 
4-7  days  before  infection  actually  resulted  in  enhancement  of  immunity. 
Similar effects on antibody production have been produced with cyclophospha- 
mide  (24),  6-mercaptopurine  (6-MP)  (25), and  cytosine  arabinoside  (26). 
Chanmougan and Schwartz (25) observed that rabbits which had been treated 
with 6-MP and rested for 1 wk before challenged  with small doses of antigen, 
produced levels of circulating  antibody considerably higher than were achieved 
by untreated animals,  an effect attributed to hyperplasia of the lymphoid sys- 
tem in the pretreated rabbits (27). Incidental observations in the present study 
also  indicated  that  mice  which  have  been  treated  with  cyclophosphamide, 
vinblastine, or methotrexate show marked shrinkage  of the spleen followed by 
gross enlargement and hyperplasia which was manifest 4 days after treatment 
with methotrexate and by the 7th day in animals  treated with cyclophospha- 
mide or vinblastine.  Since  the phase of hyperplasia  coincided  with  the  im- 
munity-enhancing effect of the drugs, lymphoid hyperplasia may indeed explain 
this paradoxical effect of drugs which are normally immunosuppressive in their 
action. If these observations have any relevance to man, inadequate medication 14  EFFECT OF CYTOTOXIC AGENTS  ON IMMUNE  RESPONSE 
during immunosuppressive  therapy may actually enhance  immunologic reac- 
tivity with possible adverse consequences. There is therefore a need for a precise 
knowledge of the time-dose relationship  of each drug for ensuring optimal im- 
munosuppressive effects. 
The drugs used in the present study are among the most widely used in the 
chemotherapy of human cancer,  and all but vinblastine are  also used as im- 
munosuppressive agents for the prevention of graft rejection and the control of 
autoimmune diseases. Since they were all found to interfere conspicuously with 
the development of resistance  to a Listeria  infection, it is not surprising  that 
infection represents  a major hazard in their clinical use. But the study has also 
shown that an experimental infection can be a very useful model with which to 
assess the immunosuppressive  activity of drugs  and the  time-course  of their 
action. 
Analogies exist between the rapid proliferation of cancer cells and that asso- 
ciated with the inductive phases of an immune response. It is therefore logical to 
assume that drugs which will inhibit cancer cells may have a similar influence on 
the host response to infection, as was found in the case of the four anticancer 
agents used in this study. The method may perhaps be employed with ad- 
vantage in the screening of anticancer agents, since the techniques  are simple, 
objective,  and quantitative. 
SITMMARY 
Four drugs, representing  four different categories of cytotoxic agents,  were 
studied for their effect on the immune response to Listeria  infection in mice. 
The development of the host's immune response is revealed  by a progressive 
change in the slope of the bacterial growth curve in spleen and liver. It has its 
onset at 24 hr  in untreated mice,  but in the presence  of effective immuno- 
suppression  the organism  multiples  uninterruptediy  until  the  animal  dies 
from  overwhelming  infection. When administered as  single injections  at the 
time of  infection,  cydophosphamide, vinblastine,  and  azathioprine  all  pro- 
duced  an  effective  immunosuppression,  characterized  by  continuous bacte- 
rial multiplication. 
Methotrexate was also immunosuppressive,  but unlike the others its effects 
were reversible. They could be sustained,  however, by further treatment. 
Studies  of the time-response  relationship  indicated that cyclophosphamide 
was highly active over a broad time-span ranging from 2 days before infection to 
4 days after infection. Vinblastine on the other hand was mzxqmally active when 
given on the day of infection, while methotrexate had its greatest effect when 
given 48 hr after infection. These differences indicate that these three drugs act 
on different cell populations involved in the host's immune response. The effects 
observed have been discussed in relation to what is known of the modes of action 
of the drugs tested. S. P. TRIPATB'Y  AND  G. B.  MACKANESS  15 
An observation of interest was the phenomenon of enhanced immunity in 
animals  treated with cyclophosphamide or vinblastine 7-11  days before, and 
with methotrexate 4  days before infection; reactive hyperplasia of lymphoid 
tissue following withdrawal of drug was again advanced as an explanation for 
the occurrence of this paradoxical effect. 
The experimental model employed is simple, requiring only routine bacterio- 
logical facilities and minimal equipment.  It seems to offer a  useful means of 
assessing the immunosuppressive activity of drugs and of determining the time- 
course of their action; it could also be of value in the screening of anticancer 
agents. 
The technical assistance of Mr. Jonathan Deissler is gratefully acknowledged. 
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